{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,25]],"date-time":"2026-09-25T05:59:35Z","timestamp":1790315975241,"version":"4.1.0"},"reference-count":0,"publisher":"Bentham Science Publishers Ltd.","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["CDT"],"published-print":{"date-parts":[[2026,9,22]]},"abstract":"<jats:sec>\n                    <jats:title>Background:<\/jats:title>\n                    <jats:p>Small interfering RNA (siRNA) therapeutics have become an important\nclass of nucleic acid medicines. Meanwhile, nucleic acid foundation models and RNA language\nmodels have demonstrated promising performance in selected RNA-related tasks and may support\nsiRNA drug design through transferable sequence representation learning.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Approach:<\/jats:title>\n                    <jats:p>This mini-review selectively surveys and critically evaluates representative nucleic acid\nfoundation models and their potential roles in siRNA design, including representation learning, lowdata\nadaptation, multitask prediction, generative design, and multi-objective optimization. Particular\nattention is given to RNA language models such as RNA-FM and RiNALMo, while DNA, regulatory,\nunified DNA\u2013RNA, and multimodal models are positioned according to their direct or contextual\nrelevance to siRNA development.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results:<\/jats:title>\n                    <jats:p>Current models can be broadly grouped into DNA genomic language models, RNA language\nmodels, epigenomic\/regulatory models, unified DNA\u2013RNA models, and multimodal biomolecular\nfoundation models. Across these categories, existing models provide complementary capabilities\nfor sequence, structure, regulatory context, and cross-modal representation, but none yet\nconstitutes a complete framework for therapeutic siRNA design.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Discussion:<\/jats:title>\n                    <jats:p>Although these models show strong transferability across genomic and RNA tasks, their\nvalue for siRNA-specific therapeutic design remains insufficiently established. A central challenge is\nthe mismatch between the natural RNA grammar and the therapeutic oligonucleotide grammar. Real\nsiRNA development requires simultaneous consideration of efficacy, specificity, chemical modification,\nstability, immunogenicity, off-target effects, delivery compatibility, and manufacturability.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion:<\/jats:title>\n                    <jats:p>Future progress will depend on modification-aware representations, therapeutic oligonucleotide\ndatasets, multimodal integration, interpretable and experimentally testable outputs, robust\ncross-dataset and cross-protocol evaluation, and Pareto-based multi-objective selection. These requirements\ndefine a practical roadmap for moving from transferable RNA representations to therapeutically\ncredible siRNA design systems.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.2174\/0113894501516654260904091333","type":"journal-article","created":{"date-parts":[[2026,9,25]],"date-time":"2026-09-25T05:22:02Z","timestamp":1790313722000},"source":"Crossref","is-referenced-by-count":0,"title":["Nucleic Acid Foundation Models for siRNA Drug Design"],"prefix":"10.2174","volume":"27","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-0636-7500","authenticated-orcid":true,"given":"Liping","family":"Ren","sequence":"first","affiliation":[{"name":"School of Healthcare Technology, Chengdu Neusoft University, Chengdu, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8526-371X","authenticated-orcid":true,"given":"Hasan","family":"Zulfiqar","sequence":"additional","affiliation":[{"name":"State Key Laboratory of CommonMechanism Research for Major Diseases, Center for AI, Peking Union Medical College, Suzhou Institute of SystemMedicine, Chinese Academy of Medical Sciences, Suzhou, Jiangsu, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0002-2113-3833","authenticated-orcid":true,"given":"Zheng","family":"Shi","sequence":"additional","affiliation":[{"name":"Clinical Genetics Laboratory, Clinical MedicalCollege &amp; Affiliated Hospital, Chengdu University, Chengdu, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0009-6226-5251","authenticated-orcid":true,"given":"Guangya","family":"Xu","sequence":"additional","affiliation":[{"name":"School of Preclinical Medicine and School ofNursing, Chengdu University, Chengdu, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1317-120X","authenticated-orcid":true,"given":"Yang","family":"Zhang","sequence":"additional","affiliation":[{"name":"State Key Laboratory of Southwestern Chinese Medicine Resources,Innovative Institute of Chinese Medicine and Pharmacy, Chengdu University of Traditional Chinese Medicine, Chengdu,China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0003-2949-1608","authenticated-orcid":true,"given":"Nanchao","family":"Luo","sequence":"additional","affiliation":[{"name":"School of Computer Science and Technology, Aba Teachers College, WenChuan, Sichuan, China"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"965","container-title":["Current Drug Targets"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.eurekaselect.com\/article\/download?doi=10.2174\/0113894501516654260904091333","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.eurekaselect.com\/258589\/article","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.eurekaselect.com\/article\/download?doi=10.2174\/0113894501516654260904091333","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,25]],"date-time":"2026-09-25T05:22:44Z","timestamp":1790313764000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.eurekaselect.com\/258589\/article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,22]]},"references-count":0,"alternative-id":["LiveAll1"],"URL":"https:\/\/doi.org\/10.2174\/0113894501516654260904091333","relation":{},"ISSN":["1389-4501"],"issn-type":[{"value":"1389-4501","type":"print"}],"subject":[],"published":{"date-parts":[[2026,9,22]]}}}